Abstract:Approximately 50% of deaths in ESRD patients are attributed to cardiovascular (CV) related pathology. Only 2.5% of ESRD patients receive a kidney transplant, while the rest rely on dialysis for survival. Peritoneal dialysis (PD) therapy has been increasingly utilized in recent years, yet there is a paucity in data characterizing the effects of PD on CV function. The goal of this study was to assess molecular changes in response to PD to understand how PD could impact prevalence of CV mortality in ESRD. We hypothesized that PD would not improve CKD‐related CV pathology despite providing support during renal insufficiency. To determine how PD effects renal and left ventricle (LV) structural and functional, organ morphology, and gene expression, 10‐week‐old male rats underwent 5/6Nx or Sham operation. Peritoneal catheters were implanted 6 weeks post‐surgery. PD was initiated 3 days later in half of the 5/6Nx and sham animals (15ml [Baxter PD‐2 2.5%] 1‐hour dwell 3x/day x 8 days) for n=6‐7 per surgical and treatment group. Echocardiography, blood collection, and urine collection were performed at baseline, 6, and 7‐weeks post‐surgery. Acute carotid blood pressure was measured week 7. Results were analyzed by two‐way ANOVA and significance determined at p<0.05. Sequencing of RNA isolated from kidney and LV was performed (n=6 per surgical group and treatment). Statistical analysis of transcriptomic results compared transcript levels from rats that received PD and those that did not. Differential gene expression was determined using the R package DESeq2. The Benjamini‐Hochberg method was used to control FDR in differential expression analysis to provide an adjusted p‐value. Transcripts with an adjusted p‐value (q‐value) <0.05 were identified as differentially expressed genes (DEGs) for subsequent pathway analysis, regardless of fold change. The list of DEGs was entered into Ingenuity Pathway Analysis (IPA) for subsequent analysis. PD had no effect on LV parameters or blood pressure in Sham or 5/6Nx rats. Blood urea nitrogen, serum creatine, SDMA and cholesterol were significantly higher in 5/6Nx rats compared to sham rats and PD attenuated that increase. Serum triglycerides were also increased in 5/6Nx compared to sham, but augmented further with PD. RNA sequencing yielded >50 million reads (100 bp in length) per sample. The mapping rate for this dataset was >96% for all samples. Transcripts were considered differentially expressed with an adjusted p‐value <0.05. This identified numerous DEGs resulting from PD in sham LV, 5/6Nx LV, sham kidney and 5/6Nx kidney tissues (853, 162, 637, and 33 DEGs, respectively). IPA analysis predicted gene changes consistent with increased inflammatory responses in both the LV and kidney tissues from sham controls receiving PD, suggesting that dialysis alone may induce multi‐organ inflammatory signaling. The DEG pattern of enrichment in LV tissue from sham rats receiving PD indicated that the “Phagosome Formation“ pathway was activated, while the “EIF2 Signaling” pathway was highly enriched and activated in kidney tissue from sham rats receiving PD. In summary, our transcriptomic analysis identified a pro‐immune/inflammatory state resulting from PD alone, even in sham‐operated controls with normal renal function. The transcriptomic data align with our physiological measurements indicating PD did not diminish or improve cardiac function in sham or 5/6Nx rats, rather PD may augment inflammatory signaling to increase risk factors for CVD and cardiac mortality.

Clinical Outcomes of Peritoneal Dialysis in End-Stage Renal Disease Patients with Liver Cirrhosis: A Propensity Score Matching Study

Effect of Liver Cirrhosis on the Outcomes of Peritoneal Dialysis

Outcome of peritoneal dialysis in cirrhotic patients with chronic renal failure

Comparative Analysis of Efficacy and Prognosis of Hemodialysis and Peritoneal Dialysis for End-Stage Renal Disease: A Meta-analysis.

Laparoscopic Versus Open Catheter Placement in Peritoneal Dialysis Patients: a Systematic Review and Meta-Analysis

Associations between liver function parameters and poor clinical outcomes in peritoneal dialysis patients

Laparoscopic Vs Open Surgical Insertion of Peritoneal Dialysis Catheters: A Propensity Score-Matched Cohort Study

Safety of laparoscopic pancreaticoduodenectomy in patients with liver cirrhosis using propensity score matching

Peritoneal dialysis outcomes in patients with nephrotic syndrome: a propensity score-matched cohort study.

Impact of Initial Dialysis Modality on the Survival of Patients with ESRD in Eastern China: a Propensity-Matched Study.

Peritoneal Dialysis for Autosomal Dominant Polycystic Kidney Disease: a Retrospective Study

Risk Factors and Outcomes of Multiple Episodes of Peritoneal Dialysis Related Bacterial Peritonitis

The Association of Individual and Regional Socioeconomic Status on Initial Peritonitis and Outcomes in Peritoneal Dialysis Patients: A Propensity Score-Matched Cohort Study.

Characteristics and Clinical Outcomes of End-Stage Renal Disease Patients on Peritoneal Dialysis for over 15 Years: A Single-Center Experience

A combination of biocompatible peritoneal dialysis solutions and residual renal function, peritoneal transport, and inflammation markers: a randomized clinical trial

The Role of Peritoneal Dialysis in the Treatment of Acute Kidney Injury in Patients With Acute-on-Chronic Liver Failure: A Prospective Brazilian Study

Peritoneal Dialysis in the Comprehensive Management of End-Stage Renal Disease Patients with Liver Cirrhosis and Ascites: Practical Aspects and Review of the Literature

The Association between Baseline Serum Lipids and Mortality in Peritoneal Dialysis Patients

The Role of an Integrated Care Model for Kidney Disease in the Development of Peritoneal Dialysis: A Single-Center Experience in China

Peritoneal dialysis in an end-stage renal disease patient with massive ascites and primary liver cancer

Transcriptomic Profiling Reveals Left Ventricle and Kidney Pathology Resulting from Peritoneal Dialysis